Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07468656) titled 'SCLC Tarlatamab Blood Collection' on March 9.
Study Type: Observational
Primary Sponsor: Duke University
Condition:
Small-cell Lung Cancer
Recruitment Status: Not recruiting
Date of First Enrollment: May 2026
Target Sample Size: 25
To know more, visit https://clinicaltrials.gov/study/NCT07468656
Disclaimer: Curated by HT Syndication....